"A lot of these deals that are getting through are the strongest companies. I don't think it will be a permanent contraction. It's just a short term pause in investments."
— Jessica Canning, director of Global Research for Dow Jones VentureSource, on the impact of the current economic downturn on healthcare deal-making. "Medical device VC nosedives 51% during first quarter 2009."